Health committee  In fact, the evaluation that is being referred to in the grant is the evaluation actually of the other funding for CADTH. So the specific programs that would be under that evaluation would be our health technology assessment program; the optimal medication prescribing and utiliza

Health committee  Because the CDR was evaluated as recently as fall 2005, and because the implementation of those measures is only now rolling out, it is not part of the evaluation that will be delivered in June.

Health committee  I understand. I can see the confusion.

Health committee  Yes, you're all right.

Health committee  Could I add to that? The deputy ministers approved and have provided funding for us to publish the minutes of the CEDAC meetings. That will start in the fall. That is a fairly significant step toward answering Mr. Fletcher's question, I think.

Health committee  We, as a matter of course, do meet with patient advocacy groups. As a matter of course, we meet with industry and industry groups. So the process is already in place; it was started at the beginning for CDR. At the very beginning of CDR we had consultation sessions with both thos

Health committee  Perhaps you'll excuse me for a second. I sometimes bemoan the fact within our organization that millions of people watch Canadian Idol, but if we were to have a show that sought the opinions of all Canadians on their opinions around health care decisions and societal values, we p

Health committee  First of all, Dr. Bennett, I understand that the patient-based care is different from population-based care, and that is something that we have to be clear on. The decisions made around reimbursement must be population-based, not individual patient-based, as you know. But the f

Health committee  Finally, perhaps I may comment on the joint oncology drug review. As Mr. Wright has indicated, it won't stay a separate system or a separate process. For now, the provinces were looking for something to get started with, and that was an efficient way of having a pilot, and it's a

Health committee  I just want to clarify. The two layers you're referring to are the regulation of drugs and then the reimbursement. Those are the two layers? That's what I was checking on. Yes, you were talking about two different layers, I think. Having two layers that deal with regulation and

Health committee  The quality of life referred to in my speech is the medical quality of life terminology, not the socio-ethical values of the society. That is a challenge to all decision-making in health care. It's a very difficult challenge.

Health committee  Yes, based on the scientific evidence, because CDR, as you know, is about the scientific and clinical evidence. Dealing with socio-ethical values, the willingness to take risk, the willingness to pay, and some of the things Mr. Wright just touched on, is outside of the CDR proces

Health committee  We're going to just talk a minute about QALYs, and that might help you, and then if you need further information I can take it further.

Health committee  I'm going to ask Mr. Tierney to answer the question, but also to refer to what we're about to implement. Thank you.

Health committee  Good afternoon, Mr. Chair and members of the committee. I'd also like to thank you for inviting us back for a second appearance, and I hope we can help you and contribute further to your study. I am Dr. Jill Sanders, the CEO and president of CADTH, and I'm joined today by Mike T